WO2016016766A3 - A process for the preparation of isavuconazonium or its salt thereof - Google Patents
A process for the preparation of isavuconazonium or its salt thereof Download PDFInfo
- Publication number
- WO2016016766A3 WO2016016766A3 PCT/IB2015/055511 IB2015055511W WO2016016766A3 WO 2016016766 A3 WO2016016766 A3 WO 2016016766A3 IB 2015055511 W IB2015055511 W IB 2015055511W WO 2016016766 A3 WO2016016766 A3 WO 2016016766A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isavuconazonium
- salt
- preparation
- iodide
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a process for the preparation of stable Isavuconazonium or its salt thereof. In particular of the present invention relates to process for the preparing of isavuconazonium sulfate, Isavuconazonium iodide hydrochloride and Boc-protected isavuconazonium iodide has purity more than 90%. The process is directed to preparation of solid amorphous form of isavuconazonium sulfate, isavuconazonium iodide hydrochloride and Boc-protected isavuconazonium iodide. The present invention process of Isavuconazonium or its salt thereof is industrially feasible, simple and cost effective to manufacture of isavuconazonium sulfate with the higher purity and better yield.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2424/MUM/2014 | 2014-07-26 | ||
| IN2424MU2014 | 2014-07-26 | ||
| IN2588/MUM/2014 | 2014-08-11 | ||
| IN2588MU2014 IN2014MU02588A (en) | 2014-08-11 | 2015-07-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2016016766A2 WO2016016766A2 (en) | 2016-02-04 |
| WO2016016766A3 true WO2016016766A3 (en) | 2016-03-24 |
Family
ID=54150472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2015/055511 Ceased WO2016016766A2 (en) | 2014-07-26 | 2015-07-21 | A process for the preparation of isavuconazonium or its salt thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2016016766A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106883226A (en) * | 2017-03-30 | 2017-06-23 | 成都绿林科技有限公司 | The preparation method of Ai Shakang azoles sulfuric esters |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106916152B (en) * | 2017-04-27 | 2019-09-17 | 扬子江药业集团有限公司 | The method of redox reaction preparation Chinese mugwort Saperconazole monosulfate |
| CN110551064B (en) * | 2018-06-01 | 2021-01-01 | 重庆世森医药科技有限公司 | Preparation method of isavuconazole sulfate and intermediate thereof |
| EP3830084B1 (en) * | 2018-08-01 | 2025-08-06 | Basilea Pharmaceutica International AG, Allschwil | Methods for purifying isavuconazonium sulfate |
| CN110128420A (en) * | 2019-05-08 | 2019-08-16 | 阴启明 | Bisulfate ion/sulfate radical type anionexchangetechnique preparation Chinese mugwort Saperconazole monosulfate method |
| CN112279846B (en) * | 2019-07-25 | 2022-05-06 | 上海医药工业研究院 | A kind of method for preparing antifungal drug isavuconazolium sulfate |
| WO2021037597A1 (en) * | 2019-08-26 | 2021-03-04 | Synthon B.V. | Isavuconazonium salts and process for preparing thereof |
| CN113024539B (en) * | 2019-12-25 | 2023-11-28 | 上海迪赛诺医药集团股份有限公司 | A kind of preparation method of isavuconazole sulfate |
| CN115215857B (en) * | 2022-08-17 | 2025-02-14 | 扬子江药业集团上海海尼药业有限公司 | Preparation method of isavuconazole sulfate |
| WO2024189550A1 (en) * | 2023-03-13 | 2024-09-19 | Apitoria Pharma Private Limited | Process for the preparation of isavuconazonium sulfate and its crystalline forms |
| CN116768879A (en) * | 2023-06-15 | 2023-09-19 | 上海方予健康医药科技有限公司 | Synthesis method of antifungal drug |
| WO2025008993A1 (en) * | 2023-07-04 | 2025-01-09 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of Glycine, N-methyl-, [2-[[[1-[1-((2R,3R)-3-[4-(4-cyanophenyl)-2-thiazolyl]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-4H-1,2,4-triazolium-4-yl]ethoxy]carbonyl]methylamino]-3-pyridinyl]methyl ester, sulfate (1:1) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6812238B1 (en) * | 1999-11-02 | 2004-11-02 | Basilea Pharmaceutica Ag | N-substituted carbamoyloxyalkyl-azolium derivatives |
-
2015
- 2015-07-21 WO PCT/IB2015/055511 patent/WO2016016766A2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6812238B1 (en) * | 1999-11-02 | 2004-11-02 | Basilea Pharmaceutica Ag | N-substituted carbamoyloxyalkyl-azolium derivatives |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106883226A (en) * | 2017-03-30 | 2017-06-23 | 成都绿林科技有限公司 | The preparation method of Ai Shakang azoles sulfuric esters |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016016766A2 (en) | 2016-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016016766A3 (en) | A process for the preparation of isavuconazonium or its salt thereof | |
| WO2015110897A3 (en) | Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | |
| IN2015KN00262A (en) | ||
| WO2016080645A3 (en) | Ammonia synthesis apparatus | |
| WO2015008218A3 (en) | Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant | |
| WO2015187774A8 (en) | 3,6-dichlorosalicylic acid compounds and related synthetic processes | |
| WO2016071435A3 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| CA2899024C (en) | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid | |
| WO2018069941A3 (en) | Polymorphic forms of venetoclax | |
| WO2016125191A3 (en) | Processes for the preparation of vortioxetine hydrobromide | |
| WO2016105172A3 (en) | A method for preparing gadobutrol | |
| IN2014MU00455A (en) | ||
| WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
| WO2015044853A3 (en) | Process for preparation of dimethyl fumarate | |
| WO2017134684A3 (en) | A process for the preparation of ibrutinib | |
| HK1255014A1 (en) | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine | |
| WO2016142819A3 (en) | Novel process for the preparation of ranolazine | |
| PH12018500872A1 (en) | Innovative preparation and crystallization of iosimenol | |
| WO2015062937A3 (en) | Disperse dyes, their preparation and their use | |
| WO2017098533A3 (en) | Process for preparation of lisdexamphetamine | |
| WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
| WO2016012938A3 (en) | Improved process for preparation of amorphous linaclotide | |
| WO2014178064A3 (en) | "an improved process for the preparation of fluvoxamine maleate" | |
| WO2016079757A3 (en) | Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives | |
| WO2017098520A8 (en) | Process for the preparation of labetalol hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15766933 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15766933 Country of ref document: EP Kind code of ref document: A2 |